戻る Agenda
SESSION 3 : New Era for Product Information in Digital Health and Pharmacovigilance
Session Chair(s)
Shun Jin, MBA
Head – BD & RA, PharmaGend Global Medical Services Pte Ltd, Singapore
Rie Matsui, RPH
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
Speaker(s)
Craig Anderson
Director, Data Standards & Continuous Improvement, Pfizer, Canada
New Era for Product Information in Digital Health and Pharmacovigilance: FHIR and Electronic Product Information (ePI)
Anne Moen, PHD, MSC, RN
Professor, Faculty of Medicine, Coordinator, Gravitate-Health , University of Oslo, Norway
Gravitate – Health ePI on FHIR in EU and beyond
Yoshihiro Aoyagi, MS
Manager, Department of Medical Information, National Cancer Center Hospital East, Japan
Current and Future e-labeling in Japan ~Considering Interoperability (HL7 FHIR) from a Health Care Professional Perspective ~
Arisa Toyoda
Pharmaceutical Safety Division, Pharmaceutical Safety, Ministry of Health, Labour and Welfare, Japan
Digital health and product information in Japan
Yuan Meng
Head of Medical Office R&D, I-Mab Biopharma , China
Updates for Pharmacovigilance initiatives in China